BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 14 analysts with an average price target of $45.25. This is a potential upside of $28.25 (166.18%) from yesterday's end of day stock price of $17.

Beam Therapeutics 's activity chart (see below) currently has 52 price targets and 76 ratings on display. The stock rating distribution of BEAM is 65.12% BUY and 34.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.7% with an average time for these price targets to be met of 70.79 days.

Highest price target for BEAM is $80, Lowest price target is $26, average price target is $51.18.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 07-Apr-2025. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 28 are a BUY (65.12%), 15 are a HOLD (34.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$80

$64.53 (417.13%)

$80

11 days ago
(07-Apr-2025)

0/8 (0%)

$64.7 (422.88%)

Buy

1 months 6 days ago
(12-Mar-2025)

1/10 (10%)

$12.38 (46.51%)

118

Hold

$40

$24.53 (158.56%)

$25

1 months 8 days ago
(10-Mar-2025)

3/6 (50%)

$14.31 (55.70%)

29

Buy

$78

$62.53 (404.20%)

$78

1 months 22 days ago
(27-Feb-2025)

0/3 (0%)

$50.89 (187.72%)

Hold

$26

$10.53 (68.07%)

$24

1 months 23 days ago
(26-Feb-2025)

7/7 (100%)

$-1.89 (-6.78%)

62

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 70.79 days on average for the stock forecasts to be realized with a an average price target met ratio 37.7

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 20 price targets and 14 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Yanan Zhu with highest potential upside - $89.53

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Rick Bienkowski with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?